{"title":"肺Q-SPECT/CT成像中CT衍生辐射剂量计算的研究","authors":"Güler Silov, Fatih Boğa","doi":"10.4274/mirt.galenos.2023.55707","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the amount of effective dose (ED) due to the computed tomography (CT) component of lung perfusion-single-photon emission computed tomography (Q-SPECT)/CT.</p><p><strong>Methods: </strong>In this single-center retrospective study, imaging data were collected from the clinic database for the period 2016-2022. The 327 patients identified were aged between 20 and 94 years. Tube voltage, tube current, pitch, gantry rotation time, volume CT dose index, and dose-length product (DLP) were recorded. The DLP was then converted to an ED using the conversion factors. The comparison of the ED between two groups was performed using the Mann-Whitney U non-parametric test.</p><p><strong>Results: </strong>ED (mean ± standard deviation, mSv) was 1.20±0.70 for the pulmonary embolism (PE) (-) and 1.54±1.04 for the PE (+) cases (p<0.05). It was observed that there was a 28% increase in the ED for the PE (+) cases. In addition, each of the PE (-) and PE (+) cases was divided into two groups according to the use of the computed tomography dose reduction (CTDR): without CTDR protocol group (non-CTDR) and with CTDR protocol group (CTDR). For those groups, ED were obtained as 0.87±0.72 and 1.55±0.47 for PE (-) cases (p<0.05); 1.56±1.17 and 1.49±0.54 for PE (+) cases (p>0.05) correspondingly. For a deeper understanding, ED was calculated for all three groups formed with different tube voltage values applied for the non-CTDR and CTDR groups.There was a 42% decrease in the ED for group 1 PE (+) compared to group 2 PE (+) (1.21±0.28, 2.07±0.91, p<0.05) and there was a 41% decrease in the ED for group 1 PE (-) compared to group 2 PE (-) cases (1.17±0.32, 1.97±0.65, p<0.05).</p><p><strong>Conclusion: </strong>It could be concluded that the effective DR protocol is the non-CTDR protocol for the PE (-) cases and the application of the tube voltage at the level of 100 kVp for the PE (+) cases.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f1/1e/MIRT-32-214.PMC10600546.pdf","citationCount":"0","resultStr":"{\"title\":\"A Study of CT-derived Radiation Dose Calculation in Lung Q-SPECT/CT Imaging.\",\"authors\":\"Güler Silov, Fatih Boğa\",\"doi\":\"10.4274/mirt.galenos.2023.55707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To investigate the amount of effective dose (ED) due to the computed tomography (CT) component of lung perfusion-single-photon emission computed tomography (Q-SPECT)/CT.</p><p><strong>Methods: </strong>In this single-center retrospective study, imaging data were collected from the clinic database for the period 2016-2022. The 327 patients identified were aged between 20 and 94 years. Tube voltage, tube current, pitch, gantry rotation time, volume CT dose index, and dose-length product (DLP) were recorded. The DLP was then converted to an ED using the conversion factors. The comparison of the ED between two groups was performed using the Mann-Whitney U non-parametric test.</p><p><strong>Results: </strong>ED (mean ± standard deviation, mSv) was 1.20±0.70 for the pulmonary embolism (PE) (-) and 1.54±1.04 for the PE (+) cases (p<0.05). It was observed that there was a 28% increase in the ED for the PE (+) cases. In addition, each of the PE (-) and PE (+) cases was divided into two groups according to the use of the computed tomography dose reduction (CTDR): without CTDR protocol group (non-CTDR) and with CTDR protocol group (CTDR). For those groups, ED were obtained as 0.87±0.72 and 1.55±0.47 for PE (-) cases (p<0.05); 1.56±1.17 and 1.49±0.54 for PE (+) cases (p>0.05) correspondingly. For a deeper understanding, ED was calculated for all three groups formed with different tube voltage values applied for the non-CTDR and CTDR groups.There was a 42% decrease in the ED for group 1 PE (+) compared to group 2 PE (+) (1.21±0.28, 2.07±0.91, p<0.05) and there was a 41% decrease in the ED for group 1 PE (-) compared to group 2 PE (-) cases (1.17±0.32, 1.97±0.65, p<0.05).</p><p><strong>Conclusion: </strong>It could be concluded that the effective DR protocol is the non-CTDR protocol for the PE (-) cases and the application of the tube voltage at the level of 100 kVp for the PE (+) cases.</p>\",\"PeriodicalId\":44681,\"journal\":{\"name\":\"Molecular Imaging and Radionuclide Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-10-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f1/1e/MIRT-32-214.PMC10600546.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Imaging and Radionuclide Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/mirt.galenos.2023.55707\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Radionuclide Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/mirt.galenos.2023.55707","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
A Study of CT-derived Radiation Dose Calculation in Lung Q-SPECT/CT Imaging.
Objectives: To investigate the amount of effective dose (ED) due to the computed tomography (CT) component of lung perfusion-single-photon emission computed tomography (Q-SPECT)/CT.
Methods: In this single-center retrospective study, imaging data were collected from the clinic database for the period 2016-2022. The 327 patients identified were aged between 20 and 94 years. Tube voltage, tube current, pitch, gantry rotation time, volume CT dose index, and dose-length product (DLP) were recorded. The DLP was then converted to an ED using the conversion factors. The comparison of the ED between two groups was performed using the Mann-Whitney U non-parametric test.
Results: ED (mean ± standard deviation, mSv) was 1.20±0.70 for the pulmonary embolism (PE) (-) and 1.54±1.04 for the PE (+) cases (p<0.05). It was observed that there was a 28% increase in the ED for the PE (+) cases. In addition, each of the PE (-) and PE (+) cases was divided into two groups according to the use of the computed tomography dose reduction (CTDR): without CTDR protocol group (non-CTDR) and with CTDR protocol group (CTDR). For those groups, ED were obtained as 0.87±0.72 and 1.55±0.47 for PE (-) cases (p<0.05); 1.56±1.17 and 1.49±0.54 for PE (+) cases (p>0.05) correspondingly. For a deeper understanding, ED was calculated for all three groups formed with different tube voltage values applied for the non-CTDR and CTDR groups.There was a 42% decrease in the ED for group 1 PE (+) compared to group 2 PE (+) (1.21±0.28, 2.07±0.91, p<0.05) and there was a 41% decrease in the ED for group 1 PE (-) compared to group 2 PE (-) cases (1.17±0.32, 1.97±0.65, p<0.05).
Conclusion: It could be concluded that the effective DR protocol is the non-CTDR protocol for the PE (-) cases and the application of the tube voltage at the level of 100 kVp for the PE (+) cases.
期刊介绍:
Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.